341/557US=84-A / Biol/Mol
Hsu FJ, Teicher BA, McPherson JM. Development of inhibitors of transforming growth factor-B signaling for therapy: rationale for anti-TGF-B antibody therapy in oncology. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 757-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FACTOR DE CRESCIMENTO TRANSFORMANTE-B; IMUNOSSUPRESSAO; METASTASE OSSEA; CARCINOMA DE CELULAS RENAIS; MELANOMA; CANCER DE MAMA; HORMONAL DO CANCER DA PROSTATA REFRATARIOS; CANCER DE PANCREAS; MIELOMA MULTIPLO; LINFOMA DE NAO-HOGGKIN; BIOMARCADORES

342/557US=440 / Tese/FAP
Sousa EA. Linfangiogênese em carcinoma epidermóide oral e associação com características clinicopatológicas. [Lymphangiogenesis in oral squamous cell carcinoma and association with clinicopathological characteristics]. São Paulo, 2012. 72 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2012/ElenAlvesSousa/ElenAlvesSousa.pdf

Curriculum Lattes

LINFANGIOGENESE; CARCINOMA DE CELULAS ESCAMOSAS; CAVIDADE ORAL; NEOPLASIAS DE CABECA E PESCOCO; IMUNOISTOQUIMICA; MARCADORES BIOLOGICOS DE TUMOR

343/557US=8-A / Dermatologia
Leonhardt JM, Heymann WR. Cutaneous manifestations of other endocrine diseases. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 1662-70. ISBN 978-0-07-138076-0.

DOENCAS ENDOCRINAS; MANIFESTACOES CUTANEAS; TIREOIDE; HIPERTIREOIDISMO; DOENCA DE GRAVES; HIPOTIREOIDISMO; HIPERPARATIREOIDISMO; HIPOPARATIREOIDISMO; GLUCOCORTICOIDES; SINDROME DE CUSHING; SINDROME DE ADDISON; HORMONIOS GONADAIS; MANIFESTACOES CUTANEAS; EXCESSO DE ANDROGENOS; DEFICIENCIA ANDROGENICA; EXCESSO DE ESTROGENIO; EXCESSO DE HORMONIO DE CRESCIMENTO; DEFICIENCIA DE HORMONIO DE CRESCIMENTO; PAN-HIPOPITUITARISMO

344/557US=90 / Biol/Mol
Domin J. EGFR signaling networks: phosphoinositide 3-kanase enzymes as downstrem targets of the EGF receptor. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 97-117. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

AKT; FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR; QUINASE; FOSFATIDILINOSITOL; TRANSDUCAO DE SINAL; CELULA; CANCER; MITOGENESE; APOPTOSE; ENDOCITOSE

345/557US=90 / Biol/Mol
Lao HJ, Carpenter G. EGFR signaling networks: nuclear ErbB receptors: pathways and functions. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 187-97. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

ERBB; FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; NUCLEO; SINALIZAR; TRANSDUCAO

346/557US=90 / Biol/Mol
Blagoev B, Kratchmarova I, Olsen JV, Mann M. EGFR signaling networks: temporal dynamics of EGF receptor signaling by quantitative proteomics. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 199-207. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; NUCLEO; SINALIZAR; TRANSDUCAO

347/557US=90 / Biol/Mol
Normanno N, Bianco C, De Luca A, Strizzi L, Gallo M, Mancino M, Salomon DS. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: expression and prognostic significance of the EGFR in solid tumors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 221-34. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EGFR; ERBB2; ERBB3; ERBB4; EGF-COMO FATOR DE CRESCIMENTO; CANCER; PROGNOSTICO

348/557US=90 / Biol/Mol
Eberhard DA. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: EGFR mutations, other molecular alterations related to sensitivity to EGFR-targeted therapies in non-small cell lung cancer. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 293-336. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; INIBIDORES DE QUINASE DE TIROSINA; DIAGNOSTICOS MOLECULARES; MUTACOES; HIBRIDACAO IN SITU FLUORESCENTE; IMUNOHISTOQUIMICA; CANCER DE PULMAO

349/557US=90 / Biol/Mol
Dannenberg AJ, Subbaramaiah K. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: crosstalk between COX-2 and EGFR: apontential therapeutic opportunity. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 337-51. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

CICLOOXIGENASE-2; PROSTAGLANDINAS; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; CROSSTALK; CANCER

350/557US=1 / Química
Bolander Junior FF. Bioquímica endócrina. In: Baynes JW, Dominiczak MH. Bioquímica médica. 2ª ed. Rio de Janeiro: Elsevier, 2007. p. 537-55. ISBN 85-3522298-2.

HORMONIOS; TIPOS DE HORMONIOS; SISTEMA REGULADOR HIPOTALAMO-HIPOFISE; EIXO HIPOTALAMICO-HIPOFISARIO-TIREOIDEANO; HORMONIOS DA GLANDULA HIPOFISE POSTERIOR; HORMONIOS DO SISTEMA REGULADOR; HORMONIO LIBERADOR DE TIREOTROPINA; HORMONIO ESTIMULADOR DA TIREOIDE; TIROXINA; TRIIODOTIRONINA; HORMONIOS DA TIREOIDE; FUNCAO DA TIREOIDE; EIXO HIPOTALAMICO-HIPOFISARIO-ADRENAL; HORMONIO ADRENOCORTICOTROPICO; BIOSSINTESE DE CORTISOL; SECRECAO DE CORTISOL; EIXO HIPOTALAMICO-HIPOFISARIO-GONADAL; HORMONIO LIBERADOR DE GONADOTROPINA; HORMONIO FOLICULO-ESTIMULANTE; HORMONIO LUTEINIZANTE; TESTOSTERONA; HORMONIOS ESTEROIDES; HORMONIO DO CRESCIMENTO; PROLACTINA

351/557US=1 / Química
Harnett MM, Goodridge HS. Crescimento celular, diferenciação e câncer. In: Baynes JW, Dominiczak MH. Bioquímica médica. 2ª ed. Rio de Janeiro: Elsevier, 2007. p. 601-17. ISBN 85-3522298-2.

CICLO CELULAR; FATORES DE CRESCIMENTO CELULAR; RECEPTOR PDGF; RECEPTOR DE CITOCINA; REGULACAO DO CICLO CELULAR; APOPTOSE; CASPASE; CANCER; ONCOGENE; GENES SUPRESSORES DE TUMOR

352/557US=1 / Quimioterapia
Brown D, Humble A. Cellular mechanisms of chemotherapy. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 1-17. ISBN 978-1-890504-68-7.

MECANISMOS CELULARES DE QUIMIOTERAPIA; CRESCIMENTO DE CELULAS NORMAIS E MALIGNAS; TRANSFORMACAO CELULAR

353/557US=1 / Quimioterapia
Gaddis JS, Gullatte MM. Pharmacologic principles of chemotherapy. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 19-37. ISBN 978-1-890504-68-7.

FARMACOLOGICOS DE QUIMIOTERAPIA; CICLO CELULAR DE RESPOSTA QUIMIOTERAPIA; AGENTES ANTINEOPLASICOS; AGENTES ALQUILANTES; TOXICIDADE DOS AGENTES ALQUILANTES; ANTIMETABOLITOS; TOXICIDADE ANTIMETABOLITO; ANTIBIOTICOS ANTITUMORAIS; FACTORES DE CRESCIMENTO HEMATOPOIETICOS; HORMONIOS; ALCALOIDES DE PLANTAS; TERAPIAS-ALVO MOLECULAR; ANTICORPOS MONOCLONAIS

354/557US=111 / Câncer
Billioux AC, Modlich U, Bicknell R. Angiogenesis. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 144-54. ISBN 978-0-470-01852-1.

CANCER; ANGIOGENESE; CRESCIMENTO TUMORAL; MORFOLOGIA DOS VASOS SANGUINEOS; VASCULATURA TUMORAL; MECANISMOS DA ANGIOGENESE; FATORES ANGIOGENICOS; COLAPSO DA MEMBRANA BASAL; MIGRACAO CELULAR; PROLIFERACAO CELULAR; FORMACAO DOS VASOS SANGUINEOS; MATURACAO DOS VASOS SANGUINEOS

355/557US=111 / Câncer
Zhu B, Kyprianou N. Transforming growth factor-beta and cancer. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 257-71. ISBN 978-0-470-01852-1.

CANCER; FATOR TRANSFORMADOR DE CRESCIMENTO BETA; FAMILIA TGF-BETA

356/557US=111-A / Câncer
Chaplain MAJ. Mathematical models of cancer growth and development. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 936-53. ISBN 978-0-470-01852-1.

CANCER; PESQUISA DO CANCER; EXPERIMENTACAO ANIMAL; MODELOS MATEMATICOS; CRESCIMENTO DO CANCER; DESENVOLVIMENTO DO CANCER

357/557US=111-A / Câncer
Riedel H. Models for tumour growth and differentiation. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 954-69. ISBN 978-0-470-01852-1.

CANCER; MODELOS DE DIFERENCIACAO; CRESCIMENTO DO TUMOR

358/557US=16 / Urologia
Schalken JA. Biology and imaging: prostate (cancer) stem cells. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 63-72. (Contemporary Cancer Research) ISBN 978-1-58829-696-2.

BIOLOGIA; IMAGEM; CANCER DE PROSTATA; CELULAS-TRONCO; RECEPTOR DE ANDROGENO; CELULAS CANCEROSAS ESTAMINAIS; C-MET PROTOONCOGENE; FATOR DE CRESCIMENTO HEPATOCITO; FATOR DE DISPERSAO; HGF / SF; IMUNOFENOTIPO; QUERATINA 14,5; QUERATINA 18; FATORES NEUROENDOCRINOS; METASTASE; SEROTONINA; CROMOGRANINA A

359/557US=16 / Urologia
Chung LWK, Huang WC, Sung SY, Wu D, Odero-Marah V, Zhau HE. Biology and imaging: cancer-host interactions. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 73-86. (Contemporary Cancer Research) ISBN 978-1-58829-696-2.

BIOLOGIA; IMAGEM; CANCER DE PROSTATA; METASTASE OSSEA; SINALIZACAO CELULAR; MODULACAO EPIGENETICA DA EXPRESSAO GENICA; TRANSICAO EPITELIAL/MESENQUIMAL; MATRIZES EXTRACELULARES; FATORES DE CRESCIMENTO; INFLAMACAO; ALVO MOLECULAR; TERAPIA; OSTEOMIMICRY; CELULAS-TRONCO; INTERACAO TUMOR ESTROMAL

360/557US=16 / Urologia
Lee C, Shah A, Liu V, Park I, Wong L, Huang X, Huang L, Fermin T, Jang T, Kundu S, Zhou V, Zhang Q, Smith N. Biology and imaging: role of transformig growth factor-B in immunotherapy of prostate cancer. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 165-74. (Contemporary Cancer Research) ISBN 978-1-58829-696-2.

BIOLOGIA; IMAGEM; FATOR DE TRANSFORMACAO DO CRESCIMENTO BETA; IMUNOTERAPIA; CANCER DE PROSTATA; TRANSFERENCIA ADOTIVA; CELULAS T CITOLITICAS; IMUNOTERAPIA; SINALIZACAO TGF-B

Primeira | Anterior | Próxima | Última